Understand how we got here — and how to move forward.


December 10, 2019

Around the nation: Intermountain releases care guidelines for vaping-linked illness

Daily Briefing

    The health system is sharing its lessons learned from treating 105 of the state's 112 cases of vaping-linked illness, in today's bite-sized hospital and health industry news from Illinois, Nebraska, and Utah.

    • Illinois: Lurie Children's Hospital of Chicago has named Thomas Shanley as its new president and CEO. The hospital earlier this year announced Shanley would replace Patrick Magoon, who retired from the positions in July. Shanley previously served as president and chief research officer at Lurie's Stanley Manne Children's Research Institute and chair of pediatrics at Northwestern University's Feinberg School of Medicine (Goldberg, Modern Healthcare, 12/6).

    • Nebraska: Nebraska Medicine and the University of Nebraska Medical Center are planning a $1 to $2 billion expansion. The expansion would include buildings for inpatient care and research, provide more space for clinical trials, and allow the medical center to improve its student recruitment efforts (Paavola, Becker's Hospital Review, 12/6).

    • Utah: Intermountain Healthcare last month published care guidelines to help clinicians detect cases of the vaping-linked illness, called EVALI, in patients. The health system released the guidelines after treating 105 of the state's 112 EVALI cases. Denitza Blagev, a pulmonary and critical-care physician at Intermountain, said the guidelines are broadly in line with CDC guidelines released in October. One difference, according to Modern Healthcare, is Intermountain advises shorter regimens of moderate-dose steroids when patients have milder symptoms (Ross Johnson, "Transformation Hub," Modern Healthcare, 12/7).

    Have a Question?


    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.